Results 111 to 120 of about 34,733 (170)

HLA‐B*44 Alleles and HLA‐DQA1*03:01 as Genetic Risk Factors for Drug‐Induced Liver Injury due to Fluoroquinolones

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aims Fluoroquinolone exposure can give rise to drug‐induced liver injury. Genetic risk factors for this form of liver injury are poorly understood but some evidence suggests that HLA genes contribute. This study aimed to characterise HLA risk factors for fluoroquinolone‐induced liver injury in a European population. Methods From
Paola Nicoletti, M. Isabel Lucena, Raul J. Andrade, Samreen Zafer, Einar S. Bjornsson, Pär Hallberg, Dominique Larrey, Mariam Molokhia, Mia Wadelius, Guruprasad P. Aithal, Ann K. Daly   +10 more
wiley   +1 more source

Molecular Investigation and Confirmation of Clinical Isolates of Escherichia coli Urinary Infections and Evaluation of Frequency of qnrA Quinolone Resistance Gene by PCR Method [PDF]

پزشکی بالینی ابن سینا
Background and Objective: Escherichia coli is responsible for 80-90% of urinary infections in outpatients and 30-50% of urinary infections in inpatients.
Maryam Adabi, Elham Abdoli, Marzieh Varasteh Shams, Fatemeh Batmani   +3 more
doaj  

Bifunctional Photocatalysts: Exploiting Proximity for Enhanced Reaction Performance

Chemistry – A European Journal, Volume 32, Issue 19, 22 May 2026.
This review covers the application of the bifunctional approach to photocatalysis as a means to attain (enhanced) enantioselectivity, and, more in general, as a strategy to enhance the catalytic performance through an effective use of short‐lived reaction intermediates.
Luigi Dolcini, Daniele Lavelli, Alberto Dal Corso, Luca Pignataro   +3 more
wiley   +1 more source

N- and O‑Prenylated Quinolones: Syntheses and <i>In Vitro</i> and <i>In Vivo</i> Antischistosomal Evaluation. [PDF]

ACS Med Chem Lett
Khethang K, Häberli C, Dube PS, Legoabe LJ, Keiser J, Beteck RM.   +5 more
europepmc   +1 more source

Regioselective Iridium-Catalyzed C(7)-H Borylation of Free <i>N</i>-H 6‑Fluoroquinolones. [PDF]

ACS Omega
Courtney E, Mulcahy J, Hickey A, Merz J, Light ME, Marder TB, McGlacken GP.   +6 more
europepmc   +1 more source

Microbiological Profile and Antimicrobial Resistance Patterns in an Intensive Care Unit: Emphasis on ESKAPE Pathogens. [PDF]

Antibiotics (Basel)
Souza LA, Bilizario Noguerol Andrade JC, Del Fiol FS.   +2 more
europepmc   +1 more source

Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence. [PDF]

Front Immunol
Li X, Zhang D, Xu J, Xu Z, Xu K, Cheng J.   +5 more
europepmc   +1 more source

Evaluation of risk factors and treatment options associated with extra-urogenital <i>Mycoplasma hominis</i> infections. [PDF]

Front Med (Lausanne)
Cao X, Tang Y, Xiao Y, Gu S, Hu L, Liu X, Hang Y, Zheng Y, Li X, Zhong Q.   +9 more
europepmc   +1 more source

Synthesis of 2‑Quinolones via Thiolate-Mediated Cyclization of (<i>E</i>)‑2-Aminocinnamic Acid Derivatives. [PDF]

ACS Omega
Kim TW, Goh NM, Cheon CH.
europepmc   +1 more source

Negative Test, Persistent Avoidance: Real-World Outcomes of Quinolone De-Labeling. [PDF]

J Clin Med
Kırdök K, Tunakan Dalgıç C, Kural RF, Galata Z, Ateş Ü, Dizdar Canbaz T, Ay E, Aslan E, Toksoy Şentürk Mİ, Karaaslan Yetemen S, Gümüşburun R, Mete Gökmen EN, Sin AZ.   +12 more
europepmc   +1 more source